The micoEST line, an expansion of the range of Dry Extract Tablets, enhances the health-promoting properties of mushrooms, traditionally appreciated in the East and Eastern Europe and now confirmed by scientific research.
The use of mushrooms grown in controlled environments and the extraction of their active substances without the use of solvents enhance the unique and distinctive activities of each species.
Ingredients
Chaga (
Inonotus obliquus (Fr.) Pilàt) sclerotium dry extract 40% polysaccharides and 30% ß-glucans 33.3%; Stabilizers: microcrystalline cellulose (cellulose gel), calcium phosphate.
How to use
Take 1 tablet two or three times a day.
Content of characterising ingredients per maximum daily dose (3 tablets)
Chaga dry extract 900 mg, polysaccharide content 360 mg, β-glucan content 270 mg
The dosages, indicated pursuant to art. 6 DL 169/2004, are intended as average values. Applications described in literature and traditional uses
Prevention of degenerative diseases (CNS, hepatic, vascular, etc.). Prevention of oncogenesis and adjuvant in cancer treatments. Viral and bacterial infection susceptibility. Carbohydrate and lipid metabolism disorders, metabolic syndrome. Skin dyscrasias.
The applications listed above do not have a prescriptive or therapeutic nature in any case.
Always consult your doctor first in case of illness or disease.
Possible side effects or interactions
It may interact with anticoagulant, antiplatelet and hypoglycemic drugs. 
